What is the optimum dose of dipyridamole for cardiac imaging?

This publication has 13 references indexed in Scilit:

• Effect of intravenous adenosine infusion on myocardial perfusion and function. Hemodynamic/angiographic and scintigraphic study.
  Circulation, 1992
• Diagnosis of ischemic heart disease with adenosine echocardiography
  Journal of the American College of Cardiology, 1991
• Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise electrocardiography.
  Circulation, 1991
• Pharmacologic Stress Imaging
  JAMA, 1991
• Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: Correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography
  Journal of the American College of Cardiology, 1990
• Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise.
  Circulation, 1990
• Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events
  The American Journal of Cardiology, 1990
• Prognostic utility of predischarge dipyridamole-thallium imaging compared to predischarge submaximal exercise electrocardiography and maximal exercise thallium imaging after uncomplicated acute myocardial infarction
  The American Journal of Cardiology, 1989
• Transient myocardial dysfunction during pharmacologic vasodilation as an index of reduced coronary reserve: A coronary hemodynamic and echocardiographic study
  Journal of the American College of Cardiology, 1986
• Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologie coronary vasodilatation
  The American Journal of Cardiology, 1978